A novel reduction of pyridinemethanols by samarium diiodide

Tetrahedron Letters

Volumn 40, Issue 50, 1999, Pages 8823-8826

  Kato, Yoshiaki ^a   Mase, Toshiaki ^a  

^a BANYU PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Alkylpyridine; Deoxygenation; Pyridinemethanols; Samarium diiodide

Indexed keywords

IODINE DERIVATIVE; METHANOL DERIVATIVE; PYRIDINE DERIVATIVE; SAMARIUM DIIODIDE; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL REACTION; CHEMICAL STRUCTURE; OXYGEN TRANSPORT; REACTION ANALYSIS; REDUCTION; SYNTHESIS;

EID: 0033544783     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0040-4039(99)01852-3     Document Type: Article

References (24)

1. (a) For thrombin inhibitors, see: Sall, D. J.; Bastian, J. A.; Briggs, S. L.; Buben, J. A.; Chirgadze, N. Y.; Clawson, D. K.; Denny, M. L.; Giera, D. D.; Grifford-Moore, D. S.; Harper, R. W.; Hauser, K. L.; Klimkowski, V. J.; Kohn, T. J.; Lin, H.-S.; McCowan, J. R.; Palkowitz, A. D.; Smith, G. F.; Takeuchi, K.; Thrasher, K. J.; Tinsley, J. M.; Utterback, B. G.; Yan, S.-C. B.; Zhang. M. J. Med. Chem. 1997, 40, 3489.
2. (b) For gastric secretion inhibitors, see: Shimada, K.; Fujisaki, H.; Oketani, K.; Murakami, M.; Shoji, T.; Wakabayashi, T.; Ueda, K.; Ema, K.; Hashimoto, K.; Tanaka, S. Chem. Pharm. Bull. 1984, 32, 4893.
3. 2/5-lipoxygenase inhibitors, see: Komatsu, Y; Minami, N. Chem. Pharm. Bull. 1995, 43, 1614.
4. (d) For purine nucleoside phosphorylase (PNP) inhibitors, see: Elliott, A. J.; Kotian, P. L.; Montgomery, J. A.; Walsh, D. A. Tetrahedron Lett. 1996, 37, 5829.
5. (e) For farnesyl protein transferase (FPT) inhibitors, see: Njoroge, F. G.; Taveraas, A. G.; Kelly, J.; Remiszewski, S.; Mallams, A. K.; Wolin, R.; Afonso, A.; Cooper, A. B.; Rane, D. F.; Liu, Y.-T.; Wong, J.; Vibulbhan, B.; Pinto, P.; Deskus, J.; Alvarez, C. S.; del Rosario, J.; Connolly, M.; Wang, J.; Desai, J.; Rossman, R. R.; Bishop, W. R.; Patton, R.; Wang, L.; Kirschmeier, P.; Bryant, M. S.; Nomeir, A. A.; Lin, C.-C.; Liu, M.; McPhail, A. T.; Doll, R. J.; Girijavallabhan, V. M.; Ganguly, A. K. J. Med. Chem. 1998, 41, 4890.
6. (a) Efange, S. M. N.; Michelson, R. H.; Remmel, R. P.; Boudreau, R. J.; Dutta, A. K.; Freshler, A. J. Med. Chem. 1990, 33, 3133.
7. (b) Bayer, H.; Hartmann, R. W. Arch. Pharm. 1991, 324, 815.
8. (c) Matulic-Adamic, J.; Beigelman, L. Tetrahedron Lett. 1997, 38, 1669.
9. (d) Uhle, F. C.; Krueger, J. E.; Rogers, A. E. J. Am. Chem. Soc. 1956, 78, 1932.
10. (e) Stoner E. J.; Cothron, D. A.; Balmer, M. K.; Roden, B. A. Tetrahedron 1995, 51, 11043.
11. (a) Ishikawa, K.; Nagase, T.; Mase, T.; Hayama, T.; Ihara, M.; Nishikibe, M.; Yano, M. WO 95/05374.
12. (b) Devine, P. N.; Dolling, U. H.; Frey, L. F.; Tillyer, R. D.; Tschaen, D. M.; Kato, Y. WO 98/06700.
13. (a) Carey, F. A.; Tremper, H. S. J. Org. Chem. 1971, 36, 758.
14. (b) Crimmins, M. T.; Rafferty, S. W. Tetrahedron Lett. 1996, 37, 5649.
15. (a) Molander, G. A. Chem. Rev. 1992, 92, 29.
16. (b) Molander, G. A. Organic Reactions 1994, 46, 211.
17. (c) Koot, W.-J.; Ley S. V. Tetrahedron 1995, 51, 2077.
18. (d) Yang, B. V.; Massa, M. A. J. Org. Chem. 1996, 61, 5149.
19. (e) Georg, G. I.; Harriman, G. C. B.; Datta, A.; Ali, S.; Cheruvallath, Z.; Dutta, D.; Vander Velde D. G.; Himes, R. H. J. Org. Chem. 1998, 63, 8926.
20. (a) Wender, P. A.; Floreancig, P. E.; Glass, T. E.; Natchus, M. G.; Shuker, A. J.; Sutton, J. C. Tetrahedron Lett. 1995, 36 4939.
21. (b) Nivlet, A.; Guen, V. L.; Dechoux, L.; Gall, T. L.; Mioskowski, C. Tetrahedron Lett. 1998, 39, 2115.
22. Kusuda, K.; Inanaga, J.; Yamaguchi, M. Tetrahedron Lett. 1989, 30, 2945.
23. 2 mediated reduction of pyridinecarboxylic acids and pyridinecarboxamides to methylpyridines includes the path via pyridinemethanol intermediates: (a) Kamochi, Y.; Kudo, T. Tetrahedron 1992, 48, 4301.
24. (b) Kamochi, Y.; Kudo, T. Heterocycles 1993, 36, 2382.